Arrowhead Pharmaceuticals
ARWR
#2055
Rank
A$13.93 B
Marketcap
A$99.56
Share price
0.30%
Change (1 day)
207.70%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): A$0.23 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$0.82 Billion. In 2024 the company made an earning of -A$0.87 Billion a decrease over its 2023 earnings that were of -A$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.23 B-126.96%
2024 -A$0.87 Billion112.45%
2023 -A$0.41 Billion87.79%
2022 -A$0.22 Billion-20.1%
2021 -A$0.28 Billion67.59%
2020 -A$0.17 Billion-347.53%
2019 A$65.18 M-245.59%
2018 -A$44.78 Million-13.17%
2017 -A$51.57 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$99.39 Million171.62%
2013 -A$36.6 Million16.56%
2012 -A$31.4 Million107.53%
2011 -A$15.13 Million
2008 -A$53.29 Million-8.07%
2007 -A$57.96 Million70.37%
2006 -A$34.02 Million122.51%
2005 -A$15.29 Million147.41%
2004 -A$6.18 Million2002.28%
2003 -A$0.3 Million-85.61%
2002 -A$2.05 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B 22,893.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.52 Billion-2,332.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$95.91 M-52.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-7.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.16 Billion-176.72%๐Ÿ‡บ๐Ÿ‡ธ USA